Movianto signed contract with Danish biotech company TopoTarget
Stuttgart, 5 October 2006
Movianto Deutschland (formerly known as Sanalog Logistik),
an operation of Movianto Group, Europe's specialised pharmaceutical
and healthcare logistics provider, has signed an exclusive
long-term contract with TopoTarget to distribute its newly
launched product Savene™.
TopoTarget A/S, a public biotech company based in Denmark,
is specialised in improving cancer therapies. The new product
Savene™, an antidote to chemotherapy accidents, has
obtained Orphan Drug status in both Europe and the US and
was recently launched in Europe.
Movianto Deutschland will provide TopoTarget with warehousing
services as well as packaging, labelling and distribution
to hospitals and oncology centres predominantly in the European
market.
Movianto Deutschland's Managing Director Thomas Creuzberger
says: "Our specialisation and knowledge of the healthcare
market ensures our customer supply chain efficiency and
flexibility in delivering the product to hospitals in several
European countries."
The two sites of Movianto Deutschland in Kist/Würzburg
and Neunkirchen/Saarland incorporate a combined storage
space for more than 18,000 pallets. Together, the two sites
provide an excellent platform that enables the company to
act as a European distribution centre for customers in the
pharmaceutical and healthcare industry.
 Download
press release as PDF
|
